Richard Alvarez

Mr. Alvarez is the principal business architect of the company and is responsible for day-to-day operations and research. Mr. Alvarez is a co-founder of Selexys Pharmaceuticals and served as COO from 2005-2008. Prior to joining Tetherex, he served as VP of Operations and Research at Selexys Pharmaceuticals from 2008 to 2016. Prior to Selexys, he was Director of the Protein-Carbohydrate Interaction Core H for the Consortium for Functional Glycomics, a large scale initiative funded by NIH to better understand the role of sugars in biology and disease. Mr. Alvarez has co-authored more than 35 scientific publications, 3 book chapters and 4 patents.